Shortening the paediatric Haemophilia Activities List (pedHAL) based on pooled data from international studies

Isolde A R Kuijlaars1, Janjaap van der Net2, Vanessa Bouskill3

  • 1Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Insights

A shorter version of the pediatric Haemophilia Activities List (pedHAL) was developed, reducing over 50% of items. The new 22-item pedHAL_short maintains measurement of activities and participation in children with hemophilia.

Area of Science:

  • Pediatric health outcomes research
  • Clinical measurement and psychometrics
  • Hematology and coagulation disorders

Background:

  • The pediatric Haemophilia Activities List (pedHAL) measures activities and participation in children with hemophilia.
  • International studies highlight the need to identify universally important items for a concise tool.
  • Optimizing measurement tools reduces patient burden and improves data collection efficiency.

Purpose of the Study:

  • To identify and remove redundant items from the original 53-item pedHAL.
  • To develop a shorter, more efficient version of the pedHAL for clinical use.
  • To maintain comprehensive assessment of activities and participation in pediatric hemophilia patients.

Main Methods:

  • Secondary analysis of pooled cross-sectional data from 6 published studies using the pedHAL.
  • Evaluation of 53 items across 7 domains in children aged 4-18 years with hemophilia A/B.
  • Statistical methods included analysis of floor/ceiling effects, missing data, inter-item correlations, factor analysis, and item-total correlations to identify redundant items.

Main Results:

  • Data from 315 pediatric hemophilia patients were analyzed.
  • A stepwise procedure removed 31 items, resulting in a 22-item pedHAL_short.
  • The pedHAL_short retained all 7 original domains, with most items in 'sitting/kneeling/standing' and 'functions of the legs'.

Conclusions:

  • A >50% reduction in the pedHAL length was achieved, creating the 22-item pedHAL_short.
  • The pedHAL_short is expected to reduce patient burden while capturing essential activity and participation information.
  • Further validation of the pedHAL_short in diverse populations is recommended.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
122
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
112
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102